Sales & Earnings In Brief
This article was originally published in The Tan Sheet
Executive Summary
Sanofi “internationalizes” OTC business; Colgate to restructure, cut workforce; Mead Johnson sales slowed by 2011 report; Mucinex extension boosts Reckitt in Q3; more Sales & Earnings In Brief
You may also be interested in...
Perrigo Launch Investments Hold Income Back, As Firm Girds For 2013
Perrigo’s consumer business’ 2012 full-year operating income, after GAAP adjustments, increased only 0.8% to $304.96 million, despite the division’s 8% revenue growth to $131 million for the fiscal year. The firm plans to launch more than 60 new products in fiscal 2013.
In Brief
FDA proposes amending ANDA-blocking petition reg; Sara Lee snaps up Tea Forté; testing by FDA, CDC find no bacteria in Enfamil formula powder; USP offers draft probiotics standards; more news In Brief.
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.